Mariner Wealth Advisors (NYC)’s Quest Diagnostics DGX Stock Holding History

Mariner Wealth Advisors (NYC)’s Portfolio DGX Stock Details DGX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	$0	Buy	+5	New	+$358	﹤0.01%	734

Other funds holding DGX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

BlackRock Advisors Wilmington, Delaware $98.8B AUM 15.8% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

DSA

Davis Selected Advisers Tucson, Arizona $23.3B AUM 26.95% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

Mariner Wealth Advisors (NYC)'s DGX Position: Q1 2015 in Review

Mariner Wealth Advisors (NYC) opened a new position in Quest Diagnostics (DGX) in Q1 2015: 5 shares worth $0. The stake represents ﹤0.01% of the portfolio and ranks #734 among its holdings.

553 funds tracked by Wall St. Rank hold DGX as of Q1 2015.

Mariner Wealth Advisors (NYC) held 5 shares of Quest Diagnostics worth $0 as of Q1 2015.
Quest Diagnostics was a new Mariner Wealth Advisors (NYC) position in Q1 2015.
Quest Diagnostics made up ﹤0.01% of Mariner Wealth Advisors (NYC)'s portfolio in Q1 2015, its #734 holding.
553 funds tracked by Wall St. Rank held Quest Diagnostics as of Q1 2015.

Based on Mariner Wealth Advisors (NYC)'s 13F filing for Q1 2015, filed 14 May 2015.